EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy

Hongbin Zhuang iD, Zhiyuan Liang, Guanwei Ma, Ayesha Qureshi, Xiaoqian Ran, Chengyun Feng, Xukun Liu, Xi Yan, Liming Shen iD

MedComm · 2024-03 · 5 (3)

DOI: 10.1002/mco2.497 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 02.03.2024. Verfasst von Hongbin Zhuang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Oceanography Shenzhen University Shenzhen P. R. China. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 444 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism spectrum disorder (ASD) has become a common neurodevelopmental disorder. The heterogeneity of ASD poses great challenges for its research and clinical translation. On the basis of reviewing the heterogeneity of ASD, this review systematically summarized the current status and progress of pathogenesis, diagnostic markers, and interventions for ASD. We provided an overview of the ASD molecular mechanisms identified by multi‐omics studies and convergent mechanism in different genetic backgrounds. The comorbidities, mechanisms associated with important physiological and metabolic abnormalities (i.e., inflammation, immunity, oxidative stress, and mitochondrial dysfunction), and gut microbial disorder in ASD were reviewed. The non‐targeted omics and targeting studies of diagnostic markers for ASD were also reviewed. Moreover, we summarized the progress and methods of behavioral and educational interventions, intervention methods related to technological devices, and research on medical interventions and potential drug targets. This review highlighted the application of high‐throughput omics methods in ASD research and emphasized the importance of seeking homogeneity from heterogeneity and exploring the convergence of disease mechanisms, biomarkers, and intervention approaches, and proposes that taking into account individuality and commonality may be the key to achieve accurate diagnosis and treatment of ASD.

Schlagwörter

Stichwörter der Autor:innen

autism spectrum disorderbiomarkerintervention therapymolecular mechanismsmulti‐omics

Autor:innen und Institutionen

  • College of Life Science and Oceanography Shenzhen University Shenzhen P. R. China.
  • Maternal and Child Health Hospital of Baoan Shenzhen P. R. China.
  • Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions Shenzhen P. R. China.

ORCID-Profile: Hongbin Zhuang, Liming Shen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhuang, H., Liang, Z., Ma, G., Qureshi, A., Ran, X., Feng, C., Liu, X., Yan, X., & Shen, L. (2024). Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy. MedComm, 5(3). https://doi.org/10.1002/mco2.497

Vancouver

Zhuang H, Liang Z, Ma G, Qureshi A, Ran X, Feng C, et al. Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy. MedComm. 2024;5(3). doi:10.1002/mco2.497

BibTeX
@article{Zhuang2024,
  author = {Zhuang, Hongbin and Liang, Zhiyuan and Ma, Guanwei and Qureshi, Ayesha and Ran, Xiaoqian and Feng, Chengyun and Liu, Xukun and Yan, Xi and Shen, Liming},
  title = {Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {3},
  doi = {10.1002/mco2.497}
}
Kostenlos starten →